Compounded GLP-1 medications are not intended to replace brand-name drugs like Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. These medications can only be prescribed when a patient has a clinical need that the commercial version cannot meet. This may include issues like ingredient intolerance, the need for added compounds such as B12 or glycine, or a preference for flexible dosing or oral options. To be considered, patients must complete a medical intake form, confirm their clinical need, and meet basic eligibility criteria such as BMI. Final approval is made by a licensed provider after reviewing your health information. Not all patients will qualify.